In a 78‑kg adult with type 1 diabetes receiving dexamethasone 2 mg, currently on insulin glargine (Lantus) 20 U daily and neutral protamine Hagedorn (NPH) 100 U at 6 pm, with the given glucose readings and carbohydrate intake, what insulin‑to‑carbohydrate ratio, insulin sensitivity factor, and adjustments to the Lantus and NPH doses should be recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Dose Adjustments for Type 1 Diabetes on Dexamethasone with Tube Feeding

Increase Lantus to 30 units daily, continue NPH 100 units at 6 PM with tube feeding initiation, use an insulin-to-carbohydrate ratio (ICR) of 1:15 for daytime boluses, and set insulin sensitivity factor (ISF) at 1:40. The current regimen is significantly underdosing for the steroid-induced hyperglycemia, as evidenced by persistent hyperglycemia throughout the 24-hour period despite 100 units of NPH.

Rationale for Dose Adjustments

Basal Insulin (Lantus) Adjustment

Your current Lantus dose of 20 units is inadequate for a 78 kg patient with type 1 diabetes, particularly when receiving dexamethasone 2 mg daily. For type 1 diabetes, basal insulin typically comprises approximately one-third of total daily insulin requirements 1. Given the steroid-induced hyperglycemia pattern and the glucose readings showing persistent elevation (267-367 mg/dL during the day, 163-273 mg/dL overnight), you need more aggressive basal coverage.

The morning glucose of 273 mg/dL after overnight tube feeding with NPH coverage indicates inadequate basal insulin. Increase Lantus from 20 to 30 units (approximately 0.38 units/kg), which remains conservative but addresses the baseline insulin resistance from dexamethasone 2. This represents a 50% increase, which is appropriate given the persistent hyperglycemia pattern 1, 3.

NPH Insulin for Tube Feeding Coverage

Continue NPH 100 units at 6 PM when tube feeding starts. For continuous tube feeding with 226g carbohydrate overnight, the guideline recommendation is 1 unit per 10-15g carbohydrate 2, 4. Your 226g carbohydrate load would require 15-23 units by this calculation alone, but you're already using 100 units, which appears appropriate given the 2 AM glucose of 243 mg/dL and 7 AM glucose of 273 mg/dL still showing hyperglycemia.

The issue is that NPH alone cannot adequately cover both the tube feeding carbohydrates AND the dexamethasone-induced hyperglycemia. Dexamethasone causes afternoon and evening hyperglycemia peaks 2, 5. The NPH 100 units is addressing the overnight tube feeding but the daytime hyperglycemia (367 at 1400,267 at 1800) requires additional intervention.

Insulin-to-Carbohydrate Ratio (ICR)

Use 1:15 ratio for daytime carbohydrate coverage (1 unit per 15g carbohydrate). For the 43g carbohydrate meals at 8 AM and 7 PM, this equals approximately 3 units of rapid-acting insulin per meal 2, 4.

Your current 1:10 ratio is too aggressive and likely contributing to the relative improvement seen by evening (267 mg/dL at 1800 vs 367 at 1400), but it's still insufficient overall. The 1:15 ratio is more conservative and appropriate for a patient on dexamethasone, where insulin resistance is increased 6, 2.

Insulin Sensitivity Factor (ISF)

Set ISF at 1:50 (1 unit lowers glucose by 50 mg/dL). Your current ISF of 1:50 during the day is reasonable but may need adjustment. Given the persistent hyperglycemia despite correction doses, consider using 1:40 for more aggressive correction, particularly during peak dexamethasone effect hours (afternoon/evening) 7.

Specific Dosing Algorithm

Morning (6 AM - 12 PM):

  • Lantus 30 units once daily (can give at any consistent time) 8
  • Meal bolus: 43g ÷ 15 = 3 units rapid-acting insulin before 8 AM meal
  • Correction dose: (Current BG - 140) ÷ 40 = correction units

Afternoon/Evening (12 PM - 6 PM):

  • Meal bolus: 43g ÷ 15 = 3 units rapid-acting insulin before 7 PM meal
  • Correction dose: (Current BG - 140) ÷ 40 = correction units
  • More aggressive corrections needed during this period due to dexamethasone peak effect 6, 2

Overnight (6 PM - 6 AM):

  • NPH 100 units at 6 PM with tube feeding initiation 2, 4
  • Correctional insulin every 6 hours using regular insulin or every 4 hours with rapid-acting 2
  • Critical: If tube feeding interrupted, start 10% dextrose infusion immediately to prevent hypoglycemia 2, 4

Key Clinical Considerations

Dexamethasone-Specific Management

Dexamethasone causes prolonged hyperglycemia throughout the day and evening, peaking 4-6 hours after administration 6, 2. Unlike prednisone, which is intermediate-acting, dexamethasone is long-acting and requires both basal insulin adjustment AND potentially NPH or additional prandial coverage 6, 5. Your current regimen underestimates this effect.

For dexamethasone-induced hyperglycemia, increasing prandial and correctional insulin by 40-60% or more is often necessary in addition to basal insulin 6. This explains why your current doses are insufficient.

Type 1 Diabetes Critical Point

Never discontinue basal insulin in type 1 diabetes, even if tube feeding is interrupted 2, 4, 7. This patient must maintain Lantus regardless of feeding status to prevent diabetic ketoacidosis. The NPH covers the tube feeding carbohydrates, but Lantus provides essential basal coverage.

Monitoring and Titration

  • Check point-of-care glucose every 4-6 hours minimum 2, 7
  • Adjust basal insulin by 10-20% every 2-3 days based on fasting glucose patterns 1, 3
  • Target glucose range: 100-180 mg/dL (5.6-10.0 mmol/L) for hospitalized patients 7
  • For hypoglycemia <70 mg/dL: reduce corresponding insulin dose by 10-20% 1, 3

Common Pitfalls to Avoid

  1. Do not rely solely on sliding scale/correctional insulin - this is reactive, not proactive, and leads to persistent hyperglycemia 9, 7
  2. Do not mix or dilute Lantus - it must be given separately, not mixed with other insulins 8
  3. Do not give Lantus intravenously - subcutaneous only 8
  4. Rotate injection sites within same region (abdomen, thigh, deltoid) to prevent lipodystrophy 8
  5. Coordinate meal delivery with insulin administration - timing is critical for tube feeding 2, 4

Expected Outcomes

With these adjustments, expect:

  • Fasting glucose 100-140 mg/dL within 3-5 days
  • Daytime glucose <180 mg/dL with appropriate meal and correction coverage
  • Reduced glucose variability overnight with adequate NPH coverage
  • Possible need for further titration as dexamethasone dose or tube feeding changes

The 2 AM glucose of 243 mg/dL and 7 AM glucose of 273 mg/dL indicate the NPH is wearing off or insufficient for the carbohydrate load plus steroid effect. Monitor closely and consider splitting NPH to twice daily (every 12 hours) if overnight hyperglycemia persists 2, 4.

References

9
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

How should I adjust the insulin and oral medication regimen for a patient with hemoglobin A1c 10% who is currently taking insulin glargine (Lantus) 16 U daily, insulin lispro (Admelog) 8 U per meal, and metformin 1000 mg twice daily?
What is the appropriate initial dosage of insulin (intravenous or subcutaneous) for a patient with hyperglycemia?
For a 27‑year‑old female on dexamethasone 20 mg daily who is currently taking 52 U of NPH insulin (Neutral Protamine Hagedorn) at 08:00 and using an insulin‑to‑carbohydrate ratio (ICR) of 3 g per unit (insulin sensitivity factor 15 mg/dL), with blood glucose readings of 213 mg/dL at 08:00, 269 mg/dL at 13:00, 96 mg/dL at 15:00, 278 mg/dL at 22:00, and 285 mg/dL at 01:00, what should the 08:00 NPH dose be, what should the ICR be, and what dose of NPH insulin should be added at 20:00?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
If a patient received dexamethasone 4 mg at 8 am and insulin glargine (Lantus) 13 units at 2 pm today, and will not receive dexamethasone tomorrow, what should the insulin glargine dose be for the next day?
Is it safe to insert a new tampon after the patient has had sexual intercourse, assuming she might still have a retained tampon?
Is there a current outbreak of pneumonic plague?
How is potassium absorbed after oral or intravenous repletion, and when do serum potassium levels peak?
What are the survival rate, neurological outcome, and overall morbidity in patients resuscitated from cardiac arrest when managed with a laryngeal mask airway (LMA) versus orotracheal intubation (ETI)?
What is the recommended approach to humidification for a patient with heart failure with reduced ejection fraction (HFrEF) who requires invasive or non‑invasive mechanical ventilation or high‑flow nasal cannula?
How should a 2-year-old with a finger abrasion caused by a wagon wheel and purulent drainage be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.